The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Global lung cancer burden attributable to environmental and occupational exposures.
 
Akshee Batra
No Relationships to Disclose
 
Chinmay Jani
No Relationships to Disclose
 
Atulya Khosla
No Relationships to Disclose
 
Amrit Paudel
No Relationships to Disclose
 
Akshit Chitkara
No Relationships to Disclose
 
Nitya Batra
No Relationships to Disclose
 
Abhinav Vyas
No Relationships to Disclose
 
Fnu Anamika
No Relationships to Disclose
 
Priya Chattopadhyay
No Relationships to Disclose
 
Tanisha Jindal
No Relationships to Disclose
 
Rohit Singh
No Relationships to Disclose
 
Gilberto Lopes
Stock and Other Ownership Interests - Biomab; CDR-Life; Immorta Bio; Lucence Diagnostics; Morphometrix; Xilis
Honoraria - AstraZeneca; Blueprint Medicines; Boehringer Ingelheim; Dr. Reddy's Laboratories; Janssen; Merck; Rigel
Consulting or Advisory Role - AstraZeneca; Coherus Biosciences; Dr. Reddy's Laboratories; Mirati Therapeutics; Pfizer; Regeneron
Research Funding - Abbvie (Inst); adaptimmune (Inst); AstraZeneca; AstraZeneca (Inst); Bavarian Nordic (Inst); Blueprint Medicines (Inst); BMS (Inst); E.R. Squibb Sons, LLC; EMD Serono (Inst); G1 Therapeutics (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Janssen (Inst); Lilly (Inst); Lucence; Lucence; Merck Sharp & Dohme (Inst); NOVARTIS (Inst); Pfizer (Inst); Rgenix (Inst); Roche (Inst); Tesaro (Inst); Xilis
Travel, Accommodations, Expenses - AstraZeneca; BeiGene; Boehringer Ingelheim; Celgene; Coherus Biosciences; Dr. Reddy's Laboratories; E.R. Squibb Sons, LLC; Ipsen; Janssen; Merck; Pfizer; Pharmacyclics; Seagen; Seagen